APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Positron Emission Tomography (PET)

PET scanner is a type of nuclear medicine imaging. The scan uses a special dye that has radioactive tracers.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

PET scanner is a type of nuclear medicine imaging. The scan uses a special dye that has radioactive tracers.

Positron-emission tomography (PET) is a nuclear medicine functional imaging technique that is used to observe metabolic processes in the body. The system detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (tracer), which is introduced into the body on a biologically active molecule. Three-dimensional images of tracer concentration within the body are then constructed by computer analysis. In modern PET-CT scanners, three-dimensional imaging is often accomplished with the aid of a CT X-ray scan performed on the patient during the same session, in the same machine.

Selected research

Market Outlook & Growth Opportunities

Global Positron Emission Tomography (PET) Market Outlook and Growth Opportunities 2026

Report ID 17391982042 January 2026191 pages

Choose your research edition.

Industry ResearchPositron Emission Tomography (PET) Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Positron Emission Tomography (PET) Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Positron Emission Tomography (PET) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Positron Emission Tomography (PET) Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Positron Emission Tomography (PET) Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

PET scanner is a type of nuclear medicine imaging. The scan uses a special dye that has radioactive tracers.

Positron-emission tomography (PET) is a nuclear medicine functional imaging technique that is used to observe metabolic processes in the body. The system detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (tracer), which is introduced into the body on a biologically active molecule. Three-dimensional images of tracer concentration within the body are then constructed by computer analysis. In modern PET-CT scanners, three-dimensional imaging is often accomplished with the aid of a CT X-ray scan performed on the patient during the same session, in the same machine.

Market competition is intense. GE, Siemens Healthcare, Philips Healthcare are the leaders of the industry. The clear market leader is GE, which holds a 37% market share. In second place is Siemens Healthcare with a 31% market share, while Philips Healthcare has a strong presence in the market.

Read the full market overview

North America is the largest sales place, with a sales market share nearly 50%. Following USA, Europe is the second largest sales place with the sales market share of 23%.

This report provides an overview of the global Positron Emission Tomography (PET) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Positron Emission Tomography (PET) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Positron Emission Tomography (PET) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Positron Emission Tomography (PET) market size, projected growth trends, production technologies, key applications, and end-use industries.

Positron Emission Tomography (PET) Segment by Company

GE

Siemens Healthcare

Philips Healthcare

Toshiba

Hitachi

Neusoft

Topgrade HealthCare

United Imaging

Positron Emission Tomography (PET) Segment by Type

PET-CT

PET-MR

Others

Positron Emission Tomography (PET) Segment by Application

Oncology

Cardiology

Neurology

Others

Positron Emission Tomography (PET) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Positron Emission Tomography (PET) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Positron Emission Tomography (PET) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Positron Emission Tomography (PET) significant trends, drivers, influence factors in global and regions.

6. To analyze Positron Emission Tomography (PET) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Positron Emission Tomography (PET) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Positron Emission Tomography (PET) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Positron Emission Tomography (PET).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Positron Emission Tomography (PET) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Positron Emission Tomography (PET) industry.

Chapter 3: Detailed analysis of Positron Emission Tomography (PET) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Positron Emission Tomography (PET) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Positron Emission Tomography (PET) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Positron Emission Tomography (PET) Industry Trends Table 2. Positron Emission Tomography (PET) Industry Drivers Table 3. Positron Emission Tomography (PET) Industry Opportunities and Challenges Table 4. Positron Emission Tomography (PET) Industry Restraints Table 5. Global Positron Emission Tomography (PET) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Positron Emission Tomography (PET) Revenue Share by Company (2021-2026) Table 7. Global Positron Emission Tomography (PET) Sales Volume by Company (Units) & (2021-2026) Table 8. Global Positron Emission Tomography (PET) Sales Volume Share by Company (2021-2026) Table 9. Global Positron Emission Tomography (PET) Average Price (k USD/Unit) of Company (2021-2026) Table 10. Global Positron Emission Tomography (PET) Company Ranking, (2024-2026) & (USD Million) Table 11. Global Positron Emission Tomography (PET) Key Company Manufacturing Base & Headquarters Table 12. Global Positron Emission Tomography (PET) Company, Product Type & Application Table 13. Global Positron Emission Tomography (PET) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Positron Emission Tomography (PET) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of PET-CT Table 18. Significant Companies of PET-MR Table 19. Significant Companies of Others Table 20. Global Positron Emission Tomography (PET) Sales Volume by Type 2021 VS 2025 VS 2032 (Units) Table 21. Global Positron Emission Tomography (PET) Sales Volume by Type (2021-2026) & (Units) Table 22. Global Positron Emission Tomography (PET) Sales Volume by Type (2027-2032) & (Units) Table 23. Global Positron Emission Tomography (PET) Sales Volume Share by Type (2021-2026) Table 24. Global Positron Emission Tomography (PET) Sales Volume Share by Type (2027-2032) Table 25. Global Positron Emission Tomography (PET) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Positron Emission Tomography (PET) Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Positron Emission Tomography (PET) Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Positron Emission Tomography (PET) Sales Value Share by Type (2021-2026) Table 29. Global Positron Emission Tomography (PET) Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Oncology Table 31. Significant Companies of Cardiology Table 32. Significant Companies of Neurology Table 33. Significant Companies of Others Table 34. Global Positron Emission Tomography (PET) Sales Volume by Application 2021 VS 2025 VS 2032 (Units) Table 35. Global Positron Emission Tomography (PET) Sales Volume by Application (2021-2026) & (Units) Table 36. Global Positron Emission Tomography (PET) Sales Volume by Application (2027-2032) & (Units) Table 37. Global Positron Emission Tomography (PET) Sales Volume Share by Application (2021-2026) Table 38. Global Positron Emission Tomography (PET) Sales Volume Share by Application (2027-2032) Table 39. Global Positron Emission Tomography (PET) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Positron Emission Tomography (PET) Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Positron Emission Tomography (PET) Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Positron Emission Tomography (PET) Sales Value Share by Application (2021-2026) Table 43. Global Positron Emission Tomography (PET) Sales Value Share by Application (2027-2032) Table 44. Global Positron Emission Tomography (PET) Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 45. Global Positron Emission Tomography (PET) Sales by Region (2021-2026) & (Units) Table 46. Global Positron Emission Tomography (PET) Sales Market Share by Region (2021-2026) Table 47. Global Positron Emission Tomography (PET) Sales by Region (2027-2032) & (Units) Table 48. Global Positron Emission Tomography (PET) Sales Market Share by Region (2027-2032) Table 49. Global Positron Emission Tomography (PET) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Positron Emission Tomography (PET) Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Positron Emission Tomography (PET) Sales Value Share by Region (2021-2026) Table 52. Global Positron Emission Tomography (PET) Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Positron Emission Tomography (PET) Sales Value Share by Region (2027-2032) Table 54. Global Positron Emission Tomography (PET) Market Average Price (k USD/Unit) by Region (2021-2026) Table 55. Global Positron Emission Tomography (PET) Market Average Price (k USD/Unit) by Region (2027-2032) Table 56. Global Positron Emission Tomography (PET) Sales by Country: 2021 VS 2025 VS 2032 (Units) Table 57. Global Positron Emission Tomography (PET) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Positron Emission Tomography (PET) Sales by Country (2021-2026) & (Units) Table 59. Global Positron Emission Tomography (PET) Sales Market Share by Country (2021-2026) Table 60. Global Positron Emission Tomography (PET) Sales by Country (2027-2032) & (Units) Table 61. Global Positron Emission Tomography (PET) Sales Market Share by Country (2027-2032) Table 62. Global Positron Emission Tomography (PET) Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Positron Emission Tomography (PET) Sales Value Market Share by Country (2021-2026) Table 64. Global Positron Emission Tomography (PET) Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Positron Emission Tomography (PET) Sales Value Market Share by Country (2027-2032) Table 66. GE Company Information Table 67. GE Business Overview Table 68. GE Positron Emission Tomography (PET) Sales (Units), Value (US$ Million), Price (k USD/Unit) and Gross Margin (2021-2026) Table 69. GE Positron Emission Tomography (PET) Product Portfolio Table 70. GE Recent Development Table 71. Siemens Healthcare Company Information Table 72. Siemens Healthcare Business Overview Table 73. Siemens Healthcare Positron Emission Tomography (PET) Sales (Units), Value (US$ Million), Price (k USD/Unit) and Gross Margin (2021-2026) Table 74. Siemens Healthcare Positron Emission Tomography (PET) Product Portfolio Table 75. Siemens Healthcare Recent Development Table 76. Philips Healthcare Company Information Table 77. Philips Healthcare Business Overview Table 78. Philips Healthcare Positron Emission Tomography (PET) Sales (Units), Value (US$ Million), Price (k USD/Unit) and Gross Margin (2021-2026) Table 79. Philips Healthcare Positron Emission Tomography (PET) Product Portfolio Table 80. Philips Healthcare Recent Development Table 81. Toshiba Company Information Table 82. Toshiba Business Overview Table 83. Toshiba Positron Emission Tomography (PET) Sales (Units), Value (US$ Million), Price (k USD/Unit) and Gross Margin (2021-2026) Table 84. Toshiba Positron Emission Tomography (PET) Product Portfolio Table 85. Toshiba Recent Development Table 86. Hitachi Company Information Table 87. Hitachi Business Overview Table 88. Hitachi Positron Emission Tomography (PET) Sales (Units), Value (US$ Million), Price (k USD/Unit) and Gross Margin (2021-2026) Table 89. Hitachi Positron Emission Tomography (PET) Product Portfolio Table 90. Hitachi Recent Development Table 91. Neusoft Company Information Table 92. Neusoft Business Overview Table 93. Neusoft Positron Emission Tomography (PET) Sales (Units), Value (US$ Million), Price (k USD/Unit) and Gross Margin (2021-2026) Table 94. Neusoft Positron Emission Tomography (PET) Product Portfolio Table 95. Neusoft Recent Development Table 96. Topgrade HealthCare Company Information Table 97. Topgrade HealthCare Business Overview Table 98. Topgrade HealthCare Positron Emission Tomography (PET) Sales (Units), Value (US$ Million), Price (k USD/Unit) and Gross Margin (2021-2026) Table 99. Topgrade HealthCare Positron Emission Tomography (PET) Product Portfolio Table 100. Topgrade HealthCare Recent Development Table 101. United Imaging Company Information Table 102. United Imaging Business Overview Table 103. United Imaging Positron Emission Tomography (PET) Sales (Units), Value (US$ Million), Price (k USD/Unit) and Gross Margin (2021-2026) Table 104. United Imaging Positron Emission Tomography (PET) Product Portfolio Table 105. United Imaging Recent Development Table 106. Key Raw Materials Table 107. Raw Materials Key Suppliers Table 108. Positron Emission Tomography (PET) Distributors List Table 109. Positron Emission Tomography (PET) Customers List Table 110. Research Programs/Design for This Report Table 111. Authors List of This Report Table 112. Secondary Sources Table 113. Primary Sources List of Figures Figure 1. Positron Emission Tomography (PET) Product Image Figure 2. Global Positron Emission Tomography (PET) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Positron Emission Tomography (PET) Sales Value (2021-2032) & (US$ Million) Figure 4. Global Positron Emission Tomography (PET) Sales (2021-2032) & (Units) Figure 5. Global Positron Emission Tomography (PET) Sales Average Price (k USD/Unit) & (2021-2032) Figure 6. Global Positron Emission Tomography (PET) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. PET-CT Image Figure 10. PET-MR Image Figure 11. Others Image Figure 12. Global Positron Emission Tomography (PET) Sales Volume by Type (2021 VS 2025 VS 2032) & (Units) Figure 13. Global Positron Emission Tomography (PET) Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Positron Emission Tomography (PET) Sales Volume Share by Type (2021-2032) Figure 15. Global Positron Emission Tomography (PET) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Positron Emission Tomography (PET) Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Positron Emission Tomography (PET) Sales Value Share by Type (2021-2032) Figure 18. Oncology Image Figure 19. Cardiology Image Figure 20. Neurology Image Figure 21. Others Image Figure 22. Global Positron Emission Tomography (PET) Sales Volume by Application (2021 VS 2025 VS 2032) & (Units) Figure 23. Global Positron Emission Tomography (PET) Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Positron Emission Tomography (PET) Sales Volume Share by Application (2021-2032) Figure 25. Global Positron Emission Tomography (PET) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Positron Emission Tomography (PET) Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Positron Emission Tomography (PET) Sales Value Share by Application (2021-2032) Figure 28. Global Positron Emission Tomography (PET) Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 29. Global Positron Emission Tomography (PET) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Positron Emission Tomography (PET) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Positron Emission Tomography (PET) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Positron Emission Tomography (PET) Sales Value (2021-2032) & (US$ Million) Figure 33. North America Positron Emission Tomography (PET) Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Positron Emission Tomography (PET) Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Positron Emission Tomography (PET) Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Positron Emission Tomography (PET) Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Positron Emission Tomography (PET) Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Positron Emission Tomography (PET) Sales Value (2021-2032) & (US$ Million) Figure 39. South America Positron Emission Tomography (PET) Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Positron Emission Tomography (PET) Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Positron Emission Tomography (PET) Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Positron Emission Tomography (PET) Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Positron Emission Tomography (PET) Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • PET-CT
  • PET-MR
  • Others
Applications
  • Oncology
  • Cardiology
  • Neurology
  • Others
Companies covered
  • GE
  • Siemens Healthcare
  • Philips Healthcare
  • Toshiba
  • Hitachi
  • Neusoft
  • Topgrade HealthCare
  • United Imaging

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Positron Emission Tomography (PET) Sales Value (2021-2032)
  4. 1.2.2 Global Positron Emission Tomography (PET) Sales Volume (2021-2032)
  5. 1.2.3 Global Positron Emission Tomography (PET) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Positron Emission Tomography (PET) Market Dynamics
  1. 2.1 Positron Emission Tomography (PET) Industry Trends
  2. 2.2 Positron Emission Tomography (PET) Industry Drivers
  3. 2.3 Positron Emission Tomography (PET) Industry Opportunities and Challenges
  4. 2.4 Positron Emission Tomography (PET) Industry Restraints
3 Positron Emission Tomography (PET) Market by Company
  1. 3.1 Global Positron Emission Tomography (PET) Company Revenue Ranking in 2025
  2. 3.2 Global Positron Emission Tomography (PET) Revenue by Company (2021-2026)
  3. 3.3 Global Positron Emission Tomography (PET) Sales Volume by Company (2021-2026)
  4. 3.4 Global Positron Emission Tomography (PET) Average Price by Company (2021-2026)
  5. 3.5 Global Positron Emission Tomography (PET) Company Ranking (2024-2026)
  6. 3.6 Global Positron Emission Tomography (PET) Company Manufacturing Base and Headquarters
  7. 3.7 Global Positron Emission Tomography (PET) Company Product Type and Application
  8. 3.8 Global Positron Emission Tomography (PET) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Positron Emission Tomography (PET) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Positron Emission Tomography (PET) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Positron Emission Tomography (PET) Market by Type
  1. 4.1 Positron Emission Tomography (PET) Type Introduction
  2. 4.1.1 PET-CT
  3. 4.1.2 PET-MR
  4. 4.1.3 Others
  5. 4.2 Global Positron Emission Tomography (PET) Sales Volume by Type
  6. 4.2.1 Global Positron Emission Tomography (PET) Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Positron Emission Tomography (PET) Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Positron Emission Tomography (PET) Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Positron Emission Tomography (PET) Sales Value by Type
  10. 4.3.1 Global Positron Emission Tomography (PET) Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Positron Emission Tomography (PET) Sales Value by Type (2021-2032)
  12. 4.3.3 Global Positron Emission Tomography (PET) Sales Value Share by Type (2021-2032)
5 Positron Emission Tomography (PET) Market by Application
  1. 5.1 Positron Emission Tomography (PET) Application Introduction
  2. 5.1.1 Oncology
  3. 5.1.2 Cardiology
  4. 5.1.3 Neurology
  5. 5.1.4 Others
  6. 5.2 Global Positron Emission Tomography (PET) Sales Volume by Application
  7. 5.2.1 Global Positron Emission Tomography (PET) Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Positron Emission Tomography (PET) Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Positron Emission Tomography (PET) Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Positron Emission Tomography (PET) Sales Value by Application
  11. 5.3.1 Global Positron Emission Tomography (PET) Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Positron Emission Tomography (PET) Sales Value by Application (2021-2032)
  13. 5.3.3 Global Positron Emission Tomography (PET) Sales Value Share by Application (2021-2032)
6 Positron Emission Tomography (PET) Regional Sales and Value Analysis
  1. 6.1 Global Positron Emission Tomography (PET) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Positron Emission Tomography (PET) Sales by Region (2021-2032)
  3. 6.2.1 Global Positron Emission Tomography (PET) Sales by Region: 2021-2026
  4. 6.2.2 Global Positron Emission Tomography (PET) Sales by Region (2027-2032)
  5. 6.3 Global Positron Emission Tomography (PET) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Positron Emission Tomography (PET) Sales Value by Region (2021-2032)
  7. 6.4.1 Global Positron Emission Tomography (PET) Sales Value by Region: 2021-2026
  8. 6.4.2 Global Positron Emission Tomography (PET) Sales Value by Region (2027-2032)
  9. 6.5 Global Positron Emission Tomography (PET) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Positron Emission Tomography (PET) Sales Value (2021-2032)
  12. 6.6.2 North America Positron Emission Tomography (PET) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Positron Emission Tomography (PET) Sales Value (2021-2032)
  15. 6.7.2 Europe Positron Emission Tomography (PET) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Positron Emission Tomography (PET) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Positron Emission Tomography (PET) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Positron Emission Tomography (PET) Sales Value (2021-2032)
  21. 6.9.2 South America Positron Emission Tomography (PET) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Positron Emission Tomography (PET) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Positron Emission Tomography (PET) Sales Value Share by Country, 2025 VS 2032
7 Positron Emission Tomography (PET) Country-level Sales and Value Analysis
  1. 7.1 Global Positron Emission Tomography (PET) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Positron Emission Tomography (PET) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Positron Emission Tomography (PET) Sales by Country (2021-2032)
  4. 7.3.1 Global Positron Emission Tomography (PET) Sales by Country (2021-2026)
  5. 7.3.2 Global Positron Emission Tomography (PET) Sales by Country (2027-2032)
  6. 7.4 Global Positron Emission Tomography (PET) Sales Value by Country (2021-2032)
  7. 7.4.1 Global Positron Emission Tomography (PET) Sales Value by Country (2021-2026)
  8. 7.4.2 Global Positron Emission Tomography (PET) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Positron Emission Tomography (PET) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Positron Emission Tomography (PET) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Positron Emission Tomography (PET) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 GE
  2. 8.1.1 GE Company Information
  3. 8.1.2 GE Business Overview
  4. 8.1.3 GE Positron Emission Tomography (PET) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 GE Positron Emission Tomography (PET) Product Portfolio
  6. 8.1.5 GE Recent Developments
  7. 8.2 Siemens Healthcare
  8. 8.2.1 Siemens Healthcare Company Information
  9. 8.2.2 Siemens Healthcare Business Overview
  10. 8.2.3 Siemens Healthcare Positron Emission Tomography (PET) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Siemens Healthcare Positron Emission Tomography (PET) Product Portfolio
  12. 8.2.5 Siemens Healthcare Recent Developments
  13. 8.3 Philips Healthcare
  14. 8.3.1 Philips Healthcare Company Information
  15. 8.3.2 Philips Healthcare Business Overview
  16. 8.3.3 Philips Healthcare Positron Emission Tomography (PET) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Philips Healthcare Positron Emission Tomography (PET) Product Portfolio
  18. 8.3.5 Philips Healthcare Recent Developments
  19. 8.4 Toshiba
  20. 8.4.1 Toshiba Company Information
  21. 8.4.2 Toshiba Business Overview
  22. 8.4.3 Toshiba Positron Emission Tomography (PET) Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Toshiba Positron Emission Tomography (PET) Product Portfolio
  24. 8.4.5 Toshiba Recent Developments
  25. 8.5 Hitachi
  26. 8.5.1 Hitachi Company Information
  27. 8.5.2 Hitachi Business Overview
  28. 8.5.3 Hitachi Positron Emission Tomography (PET) Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Hitachi Positron Emission Tomography (PET) Product Portfolio
  30. 8.5.5 Hitachi Recent Developments
  31. 8.6 Neusoft
  32. 8.6.1 Neusoft Company Information
  33. 8.6.2 Neusoft Business Overview
  34. 8.6.3 Neusoft Positron Emission Tomography (PET) Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Neusoft Positron Emission Tomography (PET) Product Portfolio
  36. 8.6.5 Neusoft Recent Developments
  37. 8.7 Topgrade HealthCare
  38. 8.7.1 Topgrade HealthCare Company Information
  39. 8.7.2 Topgrade HealthCare Business Overview
  40. 8.7.3 Topgrade HealthCare Positron Emission Tomography (PET) Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Topgrade HealthCare Positron Emission Tomography (PET) Product Portfolio
  42. 8.7.5 Topgrade HealthCare Recent Developments
  43. 8.8 United Imaging
  44. 8.8.1 United Imaging Company Information
  45. 8.8.2 United Imaging Business Overview
  46. 8.8.3 United Imaging Positron Emission Tomography (PET) Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 United Imaging Positron Emission Tomography (PET) Product Portfolio
  48. 8.8.5 United Imaging Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Positron Emission Tomography (PET) Value Chain Analysis
  2. 9.1.1 Positron Emission Tomography (PET) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Positron Emission Tomography (PET) Sales Mode & Process
  6. 9.2 Positron Emission Tomography (PET) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Positron Emission Tomography (PET) Distributors
  9. 9.2.3 Positron Emission Tomography (PET) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst